TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
In patients with primary hypercholesterolemia treated with a statin and with ldl-c above the
recommended target goal (esc 2003 recommendations ldl>=1.15 g/l) to compare the efficacy and
the safety of ezetrol added to ongoing statin and non drug therapeutic intervention (patient
motivation on diet or physical activities or both).